Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood

Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process

(2011) Jose A. Cancelas et al.   TRANSFUSION

Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products

(2010) Raymond P. Goodrich et al.   BIOLOGICALS

Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi

(2010) Maria Agapova et al.   TRANSFUSION

Transmission ofTrypanosoma cruziby Heart Transplantation

(2009) Heather Kun et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of the Mirasol platelet reduction technology system against Babesia microti in apheresis platelets and plasma

(2009) Laura Tonnetti et al.   TRANSFUSION

Chagas’ disease: lessons from routine donation testing

(2009) E. Castro   TRANSFUSION MEDICINE

Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease Patients

(2009) Tomas Duffy et al.   PLoS Neglected Tropical Diseases

Toxicity Testing of a Novel Riboflavin-Based Technology for Pathogen Reduction and White Blood Cell Inactivation

(2008) Heather L. Reddy et al.   TRANSFUSION MEDICINE REVIEWS